Ensure your Successful Entrance into the Parkinson’s Disease Market.
Combine Datamonitor Healthcare with Trialtrove to gain a competitive edge
By Daniel Chancellor, Lead Analyst
3 August 2015
I am a Lead Analyst covering the CNS and rare disease markets at Datamonitor Healthcare. I joined in early 2010, having ...
Read full bio
Entering a established market as a new player can be daunting. It’s difficult to know exactly where you should be targeting your trial, and also who you should be targeting your treatment at.
With our new infographic we’ve combined our data with sister product, Trialtrove, to provide you with a good platform to start. Whilst Datamonitor Healthcare allows you to look at future revenue potential and pin point exactly where you should be focusing your trial, Trialtrove lets you forensically analyze the current trial landscape in Parkinson’s disease.
Our infographic includes:
- The number of investigators and prevalent cases of Parkinson’s disease in the 7 major markets*
- A list of competitors and what phase their trials are currently in
- Average enrolment periods for each phase of industry sponsored trials, and
- Potential patient share segmented by drug class.
If you’d like to find out more about how Datamonitor Healthcare and Trialtrove can add value to your business, just click here.
*7 major markets include US, Japan and 5 major EU markets (France, Italy, Spain, Germany and the UK).